Loading…

Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)

We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without use of an ultrasound contrast agent. Although the United States Food and Drug Administration recently relaxed the issued warnings for perflutre...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2008-12, Vol.102 (12), p.1742-1746
Main Authors: Main, Michael L., MD, Ryan, Amy C., MS, Davis, Teresa E., BS, Albano, Maureen P., RN, Kusnetzky, Lisa L., BA, Hibberd, Mark, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863
cites cdi_FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863
container_end_page 1746
container_issue 12
container_start_page 1742
container_title The American journal of cardiology
container_volume 102
creator Main, Michael L., MD
Ryan, Amy C., MS
Davis, Teresa E., BS
Albano, Maureen P., RN
Kusnetzky, Lisa L., BA
Hibberd, Mark, MD
description We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without use of an ultrasound contrast agent. Although the United States Food and Drug Administration recently relaxed the issued warnings for perflutren-containing ultrasound contrast agents on May 13, 2008, concerns still exist regarding the safety of these compounds, particularly in critically ill patients. A retrospective analysis was performed using the Premier Perspective Database. Patients undergoing echocardiography during hospitalization were separated into those performed without contrast enhancement and those performed with perflutren lipid microsphere (PLM) injectable suspension contrast agent (Definity, Lantheus Medical Imaging, North Billerica, Massachusetts). Vital status within 1 day of the echocardiogram was available for all patients using hospital billing data. Between January 1, 2002 and October 31, 2007, 4,300,966 patients underwent transthoracic echocardiography at rest during hospitalization (unenhanced studies n = 4,242,712 and contrast-enhanced studies n = 58,254). Multivariate logistic regression analysis was used to compare 24-hour mortality, controlling for case mix and clinical covariates; 1-day mortality rates were 1.08% (n = 45,789 deaths) for patients undergoing noncontrast studies and 1.06% (n = 616 deaths) for patients undergoing contrast-enhanced examinations (p = 0.613). Multivariate logistic regression analysis revealed that, in patients undergoing an echocardiogram, patients receiving PLM injectable suspension contrast agent were 24% less likely to die within 1-day than patients not receiving a contrast agent (adjusted odds ratio = 0.76, 95% confidence interval 0.70 to 0.82). In conclusion, acute crude mortality was not increased in patients receiving PLM injectable suspension contrast agent. Multivariate logistic regression analysis revealed that, compared with patients not receiving a contrast agent, administration of PLM injectable suspension contrast agent during echocardiography was associated with a 24% decreased risk of mortality.
doi_str_mv 10.1016/j.amjcard.2008.08.019
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_230391511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000291490801401X</els_id><sourcerecordid>1609956921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863</originalsourceid><addsrcrecordid>eNqFUm2LEzEQXkTx6ulPUIIgKNzWmX3Pl5NSTk-4Q1GLfgtpdrZN3W5qkj2of8s_aGJLBb8IA3lmeGbmycwkyVOEKQJWrzdTud0oadtpBtBMoyG_l0ywqXmKHPP7yQQAspRjwc-SR85tgotYVg-TM-RQFZCXk-TXTI2e2K2xXvba75ke2LVxOx3dn9Syj9JrGrxji6EluzJ6WLErtTaxtTYrK3frPfuq_ZrJof0DzOgDZoveW-nMGKJzM0Ts2WwVSrGXt2PvtQqQLPtEK-283QfgQthFAcVFDnDBqypmOgoK9R2dlLx6nDzoZO_oyfE9TxZvr77Mr9ObD-_ez2c3qSrq0qeYYUelrGWNPCu7jroSl7hURYVFXpQZ1m1e1QWhatq2rqAG3laylA0QFXlT5efJ80PdnTU_RnJebMxoh9BSZDnkHEvEQCoPJGWNc5Y6sbN6K-1eIIi4KbERx02JuCkRDXnIe3YsPi631P7NOq4mEF4cCdIp2XdWDkq7Ey8D3gDUUcCbA4_CKO40WeFUmJOiVltSXrRG_1fK5T8VVK8HHZp-pz2506dRuEyA-BzPKl4VNIAF4Lf8N-PIyqI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230391511</pqid></control><display><type>article</type><title>Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)</title><source>ScienceDirect Journals</source><creator>Main, Michael L., MD ; Ryan, Amy C., MS ; Davis, Teresa E., BS ; Albano, Maureen P., RN ; Kusnetzky, Lisa L., BA ; Hibberd, Mark, MD</creator><creatorcontrib>Main, Michael L., MD ; Ryan, Amy C., MS ; Davis, Teresa E., BS ; Albano, Maureen P., RN ; Kusnetzky, Lisa L., BA ; Hibberd, Mark, MD</creatorcontrib><description>We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without use of an ultrasound contrast agent. Although the United States Food and Drug Administration recently relaxed the issued warnings for perflutren-containing ultrasound contrast agents on May 13, 2008, concerns still exist regarding the safety of these compounds, particularly in critically ill patients. A retrospective analysis was performed using the Premier Perspective Database. Patients undergoing echocardiography during hospitalization were separated into those performed without contrast enhancement and those performed with perflutren lipid microsphere (PLM) injectable suspension contrast agent (Definity, Lantheus Medical Imaging, North Billerica, Massachusetts). Vital status within 1 day of the echocardiogram was available for all patients using hospital billing data. Between January 1, 2002 and October 31, 2007, 4,300,966 patients underwent transthoracic echocardiography at rest during hospitalization (unenhanced studies n = 4,242,712 and contrast-enhanced studies n = 58,254). Multivariate logistic regression analysis was used to compare 24-hour mortality, controlling for case mix and clinical covariates; 1-day mortality rates were 1.08% (n = 45,789 deaths) for patients undergoing noncontrast studies and 1.06% (n = 616 deaths) for patients undergoing contrast-enhanced examinations (p = 0.613). Multivariate logistic regression analysis revealed that, in patients undergoing an echocardiogram, patients receiving PLM injectable suspension contrast agent were 24% less likely to die within 1-day than patients not receiving a contrast agent (adjusted odds ratio = 0.76, 95% confidence interval 0.70 to 0.82). In conclusion, acute crude mortality was not increased in patients receiving PLM injectable suspension contrast agent. Multivariate logistic regression analysis revealed that, compared with patients not receiving a contrast agent, administration of PLM injectable suspension contrast agent during echocardiography was associated with a 24% decreased risk of mortality.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2008.08.019</identifier><identifier>PMID: 19064035</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular ; Cardiovascular system ; Child ; Child, Preschool ; Cohort Studies ; Contrast Media - adverse effects ; Echocardiography - adverse effects ; Echocardiography - methods ; Echocardiography - mortality ; Fluorocarbons - adverse effects ; Hospital Mortality ; Hospitalization ; Humans ; Infant ; Investigative techniques, diagnostic techniques (general aspects) ; Logistic Models ; Medical sciences ; Microspheres ; Middle Aged ; Mortality ; Registries ; Regression analysis ; Retrospective Studies ; Studies ; Ultrasonic imaging ; Ultrasonic investigative techniques ; Young Adult</subject><ispartof>The American journal of cardiology, 2008-12, Vol.102 (12), p.1742-1746</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Dec 15, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863</citedby><cites>FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20980071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19064035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Main, Michael L., MD</creatorcontrib><creatorcontrib>Ryan, Amy C., MS</creatorcontrib><creatorcontrib>Davis, Teresa E., BS</creatorcontrib><creatorcontrib>Albano, Maureen P., RN</creatorcontrib><creatorcontrib>Kusnetzky, Lisa L., BA</creatorcontrib><creatorcontrib>Hibberd, Mark, MD</creatorcontrib><title>Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without use of an ultrasound contrast agent. Although the United States Food and Drug Administration recently relaxed the issued warnings for perflutren-containing ultrasound contrast agents on May 13, 2008, concerns still exist regarding the safety of these compounds, particularly in critically ill patients. A retrospective analysis was performed using the Premier Perspective Database. Patients undergoing echocardiography during hospitalization were separated into those performed without contrast enhancement and those performed with perflutren lipid microsphere (PLM) injectable suspension contrast agent (Definity, Lantheus Medical Imaging, North Billerica, Massachusetts). Vital status within 1 day of the echocardiogram was available for all patients using hospital billing data. Between January 1, 2002 and October 31, 2007, 4,300,966 patients underwent transthoracic echocardiography at rest during hospitalization (unenhanced studies n = 4,242,712 and contrast-enhanced studies n = 58,254). Multivariate logistic regression analysis was used to compare 24-hour mortality, controlling for case mix and clinical covariates; 1-day mortality rates were 1.08% (n = 45,789 deaths) for patients undergoing noncontrast studies and 1.06% (n = 616 deaths) for patients undergoing contrast-enhanced examinations (p = 0.613). Multivariate logistic regression analysis revealed that, in patients undergoing an echocardiogram, patients receiving PLM injectable suspension contrast agent were 24% less likely to die within 1-day than patients not receiving a contrast agent (adjusted odds ratio = 0.76, 95% confidence interval 0.70 to 0.82). In conclusion, acute crude mortality was not increased in patients receiving PLM injectable suspension contrast agent. Multivariate logistic regression analysis revealed that, compared with patients not receiving a contrast agent, administration of PLM injectable suspension contrast agent during echocardiography was associated with a 24% decreased risk of mortality.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cardiovascular system</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Contrast Media - adverse effects</subject><subject>Echocardiography - adverse effects</subject><subject>Echocardiography - methods</subject><subject>Echocardiography - mortality</subject><subject>Fluorocarbons - adverse effects</subject><subject>Hospital Mortality</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Infant</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Logistic Models</subject><subject>Medical sciences</subject><subject>Microspheres</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Registries</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Studies</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonic investigative techniques</subject><subject>Young Adult</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFUm2LEzEQXkTx6ulPUIIgKNzWmX3Pl5NSTk-4Q1GLfgtpdrZN3W5qkj2of8s_aGJLBb8IA3lmeGbmycwkyVOEKQJWrzdTud0oadtpBtBMoyG_l0ywqXmKHPP7yQQAspRjwc-SR85tgotYVg-TM-RQFZCXk-TXTI2e2K2xXvba75ke2LVxOx3dn9Syj9JrGrxji6EluzJ6WLErtTaxtTYrK3frPfuq_ZrJof0DzOgDZoveW-nMGKJzM0Ts2WwVSrGXt2PvtQqQLPtEK-283QfgQthFAcVFDnDBqypmOgoK9R2dlLx6nDzoZO_oyfE9TxZvr77Mr9ObD-_ez2c3qSrq0qeYYUelrGWNPCu7jroSl7hURYVFXpQZ1m1e1QWhatq2rqAG3laylA0QFXlT5efJ80PdnTU_RnJebMxoh9BSZDnkHEvEQCoPJGWNc5Y6sbN6K-1eIIi4KbERx02JuCkRDXnIe3YsPi631P7NOq4mEF4cCdIp2XdWDkq7Ey8D3gDUUcCbA4_CKO40WeFUmJOiVltSXrRG_1fK5T8VVK8HHZp-pz2506dRuEyA-BzPKl4VNIAF4Lf8N-PIyqI</recordid><startdate>20081215</startdate><enddate>20081215</enddate><creator>Main, Michael L., MD</creator><creator>Ryan, Amy C., MS</creator><creator>Davis, Teresa E., BS</creator><creator>Albano, Maureen P., RN</creator><creator>Kusnetzky, Lisa L., BA</creator><creator>Hibberd, Mark, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20081215</creationdate><title>Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)</title><author>Main, Michael L., MD ; Ryan, Amy C., MS ; Davis, Teresa E., BS ; Albano, Maureen P., RN ; Kusnetzky, Lisa L., BA ; Hibberd, Mark, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cardiovascular system</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Contrast Media - adverse effects</topic><topic>Echocardiography - adverse effects</topic><topic>Echocardiography - methods</topic><topic>Echocardiography - mortality</topic><topic>Fluorocarbons - adverse effects</topic><topic>Hospital Mortality</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Infant</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Logistic Models</topic><topic>Medical sciences</topic><topic>Microspheres</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Registries</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Studies</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonic investigative techniques</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Main, Michael L., MD</creatorcontrib><creatorcontrib>Ryan, Amy C., MS</creatorcontrib><creatorcontrib>Davis, Teresa E., BS</creatorcontrib><creatorcontrib>Albano, Maureen P., RN</creatorcontrib><creatorcontrib>Kusnetzky, Lisa L., BA</creatorcontrib><creatorcontrib>Hibberd, Mark, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Main, Michael L., MD</au><au>Ryan, Amy C., MS</au><au>Davis, Teresa E., BS</au><au>Albano, Maureen P., RN</au><au>Kusnetzky, Lisa L., BA</au><au>Hibberd, Mark, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2008-12-15</date><risdate>2008</risdate><volume>102</volume><issue>12</issue><spage>1742</spage><epage>1746</epage><pages>1742-1746</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without use of an ultrasound contrast agent. Although the United States Food and Drug Administration recently relaxed the issued warnings for perflutren-containing ultrasound contrast agents on May 13, 2008, concerns still exist regarding the safety of these compounds, particularly in critically ill patients. A retrospective analysis was performed using the Premier Perspective Database. Patients undergoing echocardiography during hospitalization were separated into those performed without contrast enhancement and those performed with perflutren lipid microsphere (PLM) injectable suspension contrast agent (Definity, Lantheus Medical Imaging, North Billerica, Massachusetts). Vital status within 1 day of the echocardiogram was available for all patients using hospital billing data. Between January 1, 2002 and October 31, 2007, 4,300,966 patients underwent transthoracic echocardiography at rest during hospitalization (unenhanced studies n = 4,242,712 and contrast-enhanced studies n = 58,254). Multivariate logistic regression analysis was used to compare 24-hour mortality, controlling for case mix and clinical covariates; 1-day mortality rates were 1.08% (n = 45,789 deaths) for patients undergoing noncontrast studies and 1.06% (n = 616 deaths) for patients undergoing contrast-enhanced examinations (p = 0.613). Multivariate logistic regression analysis revealed that, in patients undergoing an echocardiogram, patients receiving PLM injectable suspension contrast agent were 24% less likely to die within 1-day than patients not receiving a contrast agent (adjusted odds ratio = 0.76, 95% confidence interval 0.70 to 0.82). In conclusion, acute crude mortality was not increased in patients receiving PLM injectable suspension contrast agent. Multivariate logistic regression analysis revealed that, compared with patients not receiving a contrast agent, administration of PLM injectable suspension contrast agent during echocardiography was associated with a 24% decreased risk of mortality.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19064035</pmid><doi>10.1016/j.amjcard.2008.08.019</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2008-12, Vol.102 (12), p.1742-1746
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_230391511
source ScienceDirect Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular
Cardiovascular system
Child
Child, Preschool
Cohort Studies
Contrast Media - adverse effects
Echocardiography - adverse effects
Echocardiography - methods
Echocardiography - mortality
Fluorocarbons - adverse effects
Hospital Mortality
Hospitalization
Humans
Infant
Investigative techniques, diagnostic techniques (general aspects)
Logistic Models
Medical sciences
Microspheres
Middle Aged
Mortality
Registries
Regression analysis
Retrospective Studies
Studies
Ultrasonic imaging
Ultrasonic investigative techniques
Young Adult
title Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A25%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Mortality%20in%20Hospitalized%20Patients%20Undergoing%20Echocardiography%20With%20and%20Without%20an%20Ultrasound%20Contrast%20Agent%20(Multicenter%20Registry%20Results%20in%204,300,966%20Consecutive%20Patients)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Main,%20Michael%20L.,%20MD&rft.date=2008-12-15&rft.volume=102&rft.issue=12&rft.spage=1742&rft.epage=1746&rft.pages=1742-1746&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2008.08.019&rft_dat=%3Cproquest_cross%3E1609956921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-121fe5a7a71925ffef51b1bc4614345217d3674e1c8dd760709d6a5a80ee43863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230391511&rft_id=info:pmid/19064035&rfr_iscdi=true